vs
Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
CF BANKSHARES INC. is the larger business by last-quarter revenue ($15.7M vs $13.2M, roughly 1.2× TriSalus Life Sciences, Inc.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -73.9%, a 113.9% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 12.6%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 13.7%).
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
CFBK vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.7M | $13.2M |
| Net Profit | $5.7M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 43.4% | -24.8% |
| Net Margin | 40.0% | -73.9% |
| Revenue YoY | 12.6% | 59.8% |
| Net Profit YoY | 29.9% | 3.5% |
| EPS (diluted) | $0.88 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.7M | $13.2M | ||
| Q3 25 | $15.5M | $11.6M | ||
| Q2 25 | $15.6M | $11.2M | ||
| Q1 25 | $14.1M | $9.2M | ||
| Q4 24 | $14.0M | $8.3M | ||
| Q3 24 | $13.1M | $7.3M | ||
| Q2 24 | $12.6M | $7.4M | ||
| Q1 24 | $12.2M | $6.5M |
| Q4 25 | $5.7M | $-9.8M | ||
| Q3 25 | $2.3M | $-10.8M | ||
| Q2 25 | $5.0M | $-8.3M | ||
| Q1 25 | $4.4M | $-10.4M | ||
| Q4 24 | $4.4M | $-10.1M | ||
| Q3 24 | $4.2M | $-2.4M | ||
| Q2 24 | $1.7M | $-4.3M | ||
| Q1 24 | $3.1M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 43.4% | -24.8% | ||
| Q3 25 | 17.5% | -77.9% | ||
| Q2 25 | 41.1% | -65.4% | ||
| Q1 25 | 39.5% | -79.9% | ||
| Q4 24 | 36.9% | -91.8% | ||
| Q3 24 | 40.4% | -118.9% | ||
| Q2 24 | 15.4% | -111.0% | ||
| Q1 24 | 30.9% | -180.8% |
| Q4 25 | 40.0% | -73.9% | ||
| Q3 25 | 15.1% | -93.5% | ||
| Q2 25 | 32.3% | -73.9% | ||
| Q1 25 | 31.4% | -113.2% | ||
| Q4 24 | 35.2% | -122.4% | ||
| Q3 24 | 32.2% | -32.6% | ||
| Q2 24 | 13.5% | -58.8% | ||
| Q1 24 | 25.2% | -204.5% |
| Q4 25 | $0.88 | $-0.22 | ||
| Q3 25 | $0.36 | $-0.96 | ||
| Q2 25 | $0.77 | $-0.27 | ||
| Q1 25 | $0.68 | $-0.39 | ||
| Q4 24 | $0.68 | $-0.38 | ||
| Q3 24 | $0.65 | $-0.12 | ||
| Q2 24 | $0.26 | $-0.21 | ||
| Q1 24 | $0.47 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $259.0M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.4M | $-33.9M |
| Total Assets | $2.1B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $259.0M | $20.4M | ||
| Q3 25 | $272.4M | $22.7M | ||
| Q2 25 | $275.7M | $26.5M | ||
| Q1 25 | $241.0M | $13.0M | ||
| Q4 24 | $235.3M | $8.5M | ||
| Q3 24 | $233.5M | $11.3M | ||
| Q2 24 | $241.8M | $16.5M | ||
| Q1 24 | $236.9M | $4.0M |
| Q4 25 | $184.4M | $-33.9M | ||
| Q3 25 | $179.3M | $-26.7M | ||
| Q2 25 | $177.0M | $-19.4M | ||
| Q1 25 | $172.7M | $-34.4M | ||
| Q4 24 | $168.4M | $-25.9M | ||
| Q3 24 | $164.0M | $-20.4M | ||
| Q2 24 | $159.6M | $-25.3M | ||
| Q1 24 | $158.0M | $-36.0M |
| Q4 25 | $2.1B | $35.3M | ||
| Q3 25 | $2.1B | $36.5M | ||
| Q2 25 | $2.1B | $41.3M | ||
| Q1 25 | $2.1B | $28.6M | ||
| Q4 24 | $2.1B | $24.0M | ||
| Q3 24 | $2.1B | $27.5M | ||
| Q2 24 | $2.0B | $32.4M | ||
| Q1 24 | $2.0B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.7M | $-2.5M |
| Free Cash FlowOCF − Capex | $18.2M | $-2.5M |
| FCF MarginFCF / Revenue | 115.6% | -19.1% |
| Capex IntensityCapex / Revenue | 3.1% | 0.3% |
| Cash ConversionOCF / Net Profit | 3.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $33.4M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.7M | $-2.5M | ||
| Q3 25 | $5.5M | $-3.7M | ||
| Q2 25 | $8.0M | $-7.3M | ||
| Q1 25 | $2.2M | $-4.5M | ||
| Q4 24 | $14.2M | $-5.7M | ||
| Q3 24 | $-1.3M | $-10.8M | ||
| Q2 24 | $4.0M | $-13.4M | ||
| Q1 24 | $-1.2M | $-10.9M |
| Q4 25 | $18.2M | $-2.5M | ||
| Q3 25 | $5.2M | $-3.9M | ||
| Q2 25 | $7.8M | $-7.4M | ||
| Q1 25 | $2.2M | $-5.3M | ||
| Q4 24 | $13.9M | $-5.8M | ||
| Q3 24 | $-1.3M | $-11.0M | ||
| Q2 24 | $4.0M | $-13.5M | ||
| Q1 24 | $-1.2M | $-10.9M |
| Q4 25 | 115.6% | -19.1% | ||
| Q3 25 | 33.6% | -33.9% | ||
| Q2 25 | 50.3% | -66.1% | ||
| Q1 25 | 15.2% | -57.3% | ||
| Q4 24 | 99.6% | -69.7% | ||
| Q3 24 | -9.9% | -149.9% | ||
| Q2 24 | 31.6% | -183.1% | ||
| Q1 24 | -9.5% | -169.3% |
| Q4 25 | 3.1% | 0.3% | ||
| Q3 25 | 1.7% | 1.9% | ||
| Q2 25 | 0.7% | 0.8% | ||
| Q1 25 | 0.4% | 8.2% | ||
| Q4 24 | 1.9% | 0.6% | ||
| Q3 24 | 0.2% | 2.3% | ||
| Q2 24 | 0.1% | 0.8% | ||
| Q1 24 | 0.0% | 1.0% |
| Q4 25 | 3.26× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 3.21× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 2.35× | — | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
